Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.80
+0.07 (0.91%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $229.18 million as of July 31, 2026. Its market cap has decreased by -31.28% in one year.
Market Cap
229.18M
Enterprise Value
122.39M
1-Year Change
-31.28%
Ranking
Category
Stock Price
$7.80
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $229.18M, an increase of 38.00%. That is a compound annual growth rate of 12.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 229.18M | 22.24% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 247.77M |
| Entrada Therapeutics | 244.67M |
| ProQR Therapeutics | 242.73M |
| Orchestra BioMed Holdings | 238.33M |
| MacroGenics | 234.55M |
| Capricor Therapeutics | 222.96M |
| Conexeu Sciences | 222.36M |
| Compugen | 222.27M |